Biological use influences the impact of inflammation on risk of major adverse cardiovascular events in rheumatoid arthritis

By sjmartinez • July 24, 2024

Karpouzas GA, Ormseth SR, van Riel PLCM, Gonzalez-Gay MA, Corrales A, Rantapää-Dahlqvist S, Sfikakis PP, Dessein P, Tsang L, Hitchon C, El-Gabalawy H, Pascual-Ramos V, Contreras-Yáñez I, Colunga-Pedraza IJ, Galarza-Delgado DA, Azpiri-Lopez JR, Semb AG, Misra DP, Hauge EM, Kitas G. Biological use influences the impact of inflammation on risk of major adverse cardiovascular events in rheumatoid arthritis. RMD Open. 2024 Jul 23;10(3):e004546. doi: 10.1136/rmdopen-2024-004546. PMID: 39043615.

Tags: Arthritis, biological therapy, cardiovascular diseases, Harbor UCLA, Inflammation, Publications, Rheumatoid, Rheumatology

Pulmonary Embolism in Women in the Era of Expanding Advanced Therapies

Ishaaya E, Yang K, Seo J, Vintch J, Chung J. Pulmonary Embolism in Women in the Era of Expanding Advanced Therapies. Curr Cardiol Rep. 2025[...]

Medication Beliefs Regarding P2Y12 Inhibitors: An Exploratory Thematic and Semantic Analysis to Better Understand the Key Barriers to Medication Adherence

Lee JSG, Choi Y, Tejuco K, Heng F, Kesarwani M. Medication Beliefs Regarding P2Y12 Inhibitors: An Exploratory Thematic and Semantic Analysis to Better Understand the[...]

Bisphosphonate Use and Cardiovascular Outcomes According to Kidney Function Status in Post-Menopausal Women: An Emulated Target Trial from the Multi-Ethnic Study of Atherosclerosis

Ghotbi E, Subhas N, Bancks MP, Elmariah S, Halperin JL, Bluemke DA, Kestenbaum BR, Barr RG, Post WS, Budoff M, Lima JAC, Demehri S. Bisphosphonate[...]